{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,6]],"date-time":"2026-06-06T18:59:41Z","timestamp":1780772381375,"version":"3.54.1"},"reference-count":73,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2026,6,6]],"date-time":"2026-06-06T00:00:00Z","timestamp":1780704000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,6,6]],"date-time":"2026-06-06T00:00:00Z","timestamp":1780704000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["DARU J Pharm Sci"],"DOI":"10.1007\/s40199-026-00616-y","type":"journal-article","created":{"date-parts":[[2026,6,6]],"date-time":"2026-06-06T18:36:32Z","timestamp":1780770992000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Gastrodin as a nephroprotective agent: Molecular docking\u2013based modulation of oxidative stress, fibrosis, and inflammation"],"prefix":"10.1007","volume":"34","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-8547-2263","authenticated-orcid":false,"given":"Anish","family":"Singh","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Priya","family":"Sahani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1707-6135","authenticated-orcid":false,"given":"Diksha","family":"Dalal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2903-4293","authenticated-orcid":false,"given":"Lovedeep","family":"Singh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,6,6]]},"reference":[{"issue":"1","key":"616_CR1","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1038\/s41572-024-00589-9","volume":"11","author":"P Romagnani","year":"2025","unstructured":"Romagnani P, Agarwal R, Chan JCN, Levin A, Kalyesubula R, Karam S, Nangaku M, Rodr\u00edguez-Iturbe B, Anders HJ. Chronic kidney disease. Nat Rev Dis Primers. 2025;11(1):8. https:\/\/doi.org\/10.1038\/s41572-024-00589-9.","journal-title":"Nat Rev Dis Primers"},{"issue":"6","key":"616_CR2","doi-asserted-by":"publisher","first-page":"686","DOI":"10.23876\/j.krcp.23.001","volume":"42","author":"CW Kung","year":"2023","unstructured":"Kung CW, Chou YH. Acute kidney disease: an overview of the epidemiology, pathophysiology, and management. Kidney Res Clin Pract. 2023;42(6):686\u201399. https:\/\/doi.org\/10.23876\/j.krcp.23.001.","journal-title":"Kidney Res Clin Pract"},{"key":"616_CR3","doi-asserted-by":"publisher","unstructured":"2019 GBD. Global Burden of Disease Study: CKD metrics. Lancet. 2020;395(10225):709\u201333. https:\/\/doi.org\/10.1016\/S0140-6736(20)30566-5.","DOI":"10.1016\/S0140-6736(20)30566-5"},{"key":"616_CR4","doi-asserted-by":"publisher","unstructured":"2019 GBD. DALYs and mortality for CKD. Lancet. 2020;395(10225):709\u201333. https:\/\/doi.org\/10.1016\/S0140-6736(20)30566-5.","DOI":"10.1016\/S0140-6736(20)30566-5"},{"issue":"1","key":"616_CR5","doi-asserted-by":"publisher","first-page":"3519","DOI":"10.1186\/s12889-024-21065-9","volume":"24","author":"K Qin","year":"2024","unstructured":"Qin K, Qing J, Wang Q, Li Y. Epidemiological shifts in chronic kidney disease: a 30-year global and regional assessment. BMC Public Health. 2024;24(1):3519. https:\/\/doi.org\/10.1186\/s12889-024-21065-9.","journal-title":"BMC Public Health"},{"key":"616_CR6","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1186\/s13578-015-0056-4","volume":"5","author":"H Zhang","year":"2015","unstructured":"Zhang H, Sun SC. NF-\u03baB in inflammation and renal diseases. Cell Biosci. 2015;5:63. https:\/\/doi.org\/10.1186\/s13578-015-0056-4.","journal-title":"Cell Biosci"},{"issue":"14","key":"616_CR7","doi-asserted-by":"publisher","first-page":"2801","DOI":"10.1113\/jp284289","volume":"601","author":"U Rende","year":"2023","unstructured":"Rende U, Guller A, Goldys EM, Pollock C, Saad S. Diagnostic and prognostic biomarkers for tubulointerstitial fibrosis. J Physiol. 2023;601(14):2801\u201326. https:\/\/doi.org\/10.1113\/jp284289.","journal-title":"J Physiol"},{"key":"616_CR8","doi-asserted-by":"publisher","first-page":"1082281","DOI":"10.3389\/fphar.2023.108228","volume":"14","author":"Y Wen","year":"2023","unstructured":"Wen Y, Zhang X, Wei L, Wu M, Cheng Y, Zheng H, Shen A, Fu C, Ali F, Long L, Lu Y. Gastrodin attenuates renal injury and collagen deposition via suppression of the TGF-\u03b21\/Smad2\/3 signaling pathway based on network pharmacology analysis. Front Pharmacol. 2023;14:1082281. https:\/\/doi.org\/10.3389\/fphar.2023.108228.","journal-title":"Front Pharmacol"},{"issue":"1","key":"616_CR9","doi-asserted-by":"publisher","first-page":"759","DOI":"10.1007\/s11033-025-10846-z","volume":"52","author":"WA Kamel","year":"2025","unstructured":"Kamel WA, Haghi M, Khosroshahi HT, Dehghan G. The association of RAGE gene polymorphisms with inflammatory and oxidative stress markers in diabetic kidney disease patients. Mol Biol Rep. 2025;52(1):759. https:\/\/doi.org\/10.1007\/s11033-025-10846-z.","journal-title":"Mol Biol Rep"},{"issue":"2","key":"616_CR10","doi-asserted-by":"publisher","first-page":"215","DOI":"10.1007\/s11255-024-04162-x","volume":"56","author":"W Wang","year":"2024","unstructured":"Wang W, Hu Y, Ding N, Wei J, Li C. Role of SIRT1 in kidney diseases: A mechanistic overview. Int Urol Nephrol. 2024;56(2):215\u201328. https:\/\/doi.org\/10.1007\/s11255-024-04162-x.","journal-title":"Int Urol Nephrol"},{"issue":"5","key":"616_CR11","doi-asserted-by":"publisher","first-page":"456","DOI":"10.1177\/0192623318796784","volume":"46","author":"J Wang","year":"2018","unstructured":"Wang J, Zhong J, Yang HC, Fogo AB. Cross-talk from tubules to glomeruli. Toxicol Pathol. 2018;46(5):456\u201368. https:\/\/doi.org\/10.1177\/0192623318796784.","journal-title":"Toxicol Pathol"},{"issue":"11","key":"616_CR12","doi-asserted-by":"publisher","first-page":"2975","DOI":"10.1038\/s41401-025-01476-z","volume":"46","author":"YN Wang","year":"2025","unstructured":"Wang YN, Wu X, Shan QY, Yang Q, Yu XY, Yang JH, Miao H, Cao G, Zhao YY. Acteoside-containing caffeic acid is bioactive functional group of antifibrotic effect by suppressing inflammation via inhibiting AHR nuclear translocation in chronic kidney disease. Acta Pharmacol Sin. 2025;46(11):2975\u201388. https:\/\/doi.org\/10.1038\/s41401-025-01476-z.","journal-title":"Acta Pharmacol Sin"},{"issue":"6","key":"616_CR13","doi-asserted-by":"publisher","first-page":"1539","DOI":"10.1038\/s41401-025-01476-z","volume":"46","author":"BR Zhao","year":"2025","unstructured":"Zhao BR, Hu XR, Wang WD, Zhou Y. Cardiorenal syndrome: clinical diagnosis, molecular mechanisms and therapeutic strategies. Acta Pharmacol Sin. 2025;46(6):1539\u201355. https:\/\/doi.org\/10.1038\/s41401-025-01476-z.","journal-title":"Acta Pharmacol Sin"},{"key":"616_CR14","doi-asserted-by":"publisher","first-page":"157496","DOI":"10.1016\/j.phymed.2025.157496","volume":"148","author":"CH Jiang","year":"2025","unstructured":"Jiang CH, Zhang SJ, Li P, Miao H, Zhao YY. Natural products targeting TGF-\u03b2\/Smad signaling in renal fibrosis: Multiomics-based novel molecular mechanisms and therapeutic strategies. Phytomedicine. 2025;148:157496. https:\/\/doi.org\/10.1016\/j.phymed.2025.157496.","journal-title":"Phytomedicine"},{"issue":"2","key":"616_CR15","doi-asserted-by":"publisher","first-page":"e23","DOI":"10.1097\/IMNA-D-23-00024","volume":"11","author":"H Zhao","year":"2024","unstructured":"Zhao H, Zhao T, Li P. Gut microbiota-derived metabolites: a new perspective of traditional Chinese medicine against diabetic kidney disease. Integr Med Nephrol Androl. 2024;11(2):e23\u201300024. https:\/\/doi.org\/10.1097\/IMNA-D-23-00024.","journal-title":"Integr Med Nephrol Androl"},{"issue":"2","key":"616_CR16","doi-asserted-by":"publisher","first-page":"e22","DOI":"10.1097\/IMNA-D-22-00016","volume":"11","author":"X Zhong","year":"2024","unstructured":"Zhong X, Jia J, Tan R, Wang L. Hederagenin improves adriamycin-induced nephropathy by inhibiting the JAK\/STAT signaling pathway. Integr Med Nephrol Androl. 2024;11(2):e22\u201300016. https:\/\/doi.org\/10.1097\/IMNA-D-22-00016.","journal-title":"Integr Med Nephrol Androl"},{"issue":"11","key":"616_CR17","doi-asserted-by":"publisher","first-page":"5441","DOI":"10.1002\/ptr.8324","volume":"38","author":"YN Wang","year":"2024","unstructured":"Wang YN, Li XJ, Wang WF, Zou L, Miao H, Zhao YY. Geniposidic Acid Attenuates Chronic Tubulointerstitial Nephropathy Through Regulation of the NF-\u0199B\/Nrf2 Pathway Via Aryl Hydrocarbon Receptor Signaling. Phytother Res. 2024;38(11):5441\u201357. https:\/\/doi.org\/10.1002\/ptr.8324.","journal-title":"Phytother Res"},{"issue":"6","key":"616_CR18","doi-asserted-by":"publisher","first-page":"3781","DOI":"10.1007\/s00210-023-02920-9","volume":"397","author":"Y Wang","year":"2024","unstructured":"Wang Y, Bai M, Wang X, Peng Z, Cai C, Xi J, Yan C, Luo J, Li X. Gastrodin: a comprehensive pharmacological review. Naunyn Schmiedebergs Arch Pharmacol. 2024;397(6):3781\u2013802. https:\/\/doi.org\/10.1007\/s00210-023-02920-9.","journal-title":"Naunyn Schmiedebergs Arch Pharmacol"},{"key":"616_CR19","doi-asserted-by":"publisher","first-page":"1494277","DOI":"10.3389\/fphar.2024.1494277","volume":"15","author":"Z Shi","year":"2024","unstructured":"Shi Z, Zhang Y, Xiao Y, Shi Z, Wei X, Wang B, Yuan Y, Li P. The protective effects of gastrodin on neurological disorders: an update and future perspectives. Front Pharmacol. 2024;15:1494277. https:\/\/doi.org\/10.3389\/fphar.2024.1494277.","journal-title":"Front Pharmacol"},{"issue":"2","key":"616_CR20","doi-asserted-by":"publisher","first-page":"168","DOI":"10.3892\/etm.2021.11091","volume":"23","author":"L Huang","year":"2022","unstructured":"Huang L, Shao M, Zhu Y. Gastrodin inhibits high glucose-induced inflammation, oxidative stress and apoptosis in podocytes by activating the AMPK\/Nrf2 signaling pathway. Exp Ther Med. 2022;23(2):168. https:\/\/doi.org\/10.3892\/etm.2021.11091.","journal-title":"Exp Ther Med"},{"issue":"3","key":"616_CR21","doi-asserted-by":"publisher","first-page":"1162","DOI":"10.7150\/ijbs.120307","volume":"22","author":"H Ding","year":"2026","unstructured":"Ding H, Wang WX, Liang QD, Tang CF, Xu TD, Miao ZA, Han BX, Kong LD. Gastrodin alleviates high fructose-induced podocyte mitochondria-mediated apoptosis by inhibiting NLRP6 to facilitate TRIM7-triggered Bok mRNA degradation. Int J Biol Sci. 2026;22(3):1162. https:\/\/doi.org\/10.7150\/ijbs.120307.","journal-title":"Int J Biol Sci"},{"issue":"12","key":"616_CR22","doi-asserted-by":"publisher","first-page":"1690","DOI":"10.3390\/ph17121690","volume":"17","author":"HH Arab","year":"2024","unstructured":"Arab HH, Althobaiti MM, Alharthi AS, Almalki EO, Alsoubie SS, Qattan JM, Almalki SA, Ashour AM, Eid AH. Repurposing Dapagliflozin for Mitigation of the Kidney Injury Triggered by Cadmium in Rats: Role of Autophagy, Apoptosis, and the SIRT1\/Nrf2\/HO-1 Pathway. Pharmaceuticals. 2024;17(12):1690. https:\/\/doi.org\/10.3390\/ph17121690.","journal-title":"Pharmaceuticals"},{"key":"616_CR23","doi-asserted-by":"publisher","unstructured":"Orji OU, Awoke NJ, Uti DE, Obasi OD, Aja PM, Nwamaka EN, Umoru GU, Ogbu PN, Udoudoh MP, Alum EU, Ogbu CO. The Therapeutic Role of Gastrodin in Combating Insulin Resistance, Inflammation, and Oxidative Stress Induced by Bisphenol-A. Nat Prod Commun. 2024;19(12). https:\/\/doi.org\/10.1177\/1934578X241310096.","DOI":"10.1177\/1934578X241310096"},{"issue":"5","key":"616_CR24","doi-asserted-by":"publisher","first-page":"2728","DOI":"10.1007\/s12035-023-03743-8","volume":"61","author":"HJ Zuo","year":"2024","unstructured":"Zuo HJ, Wang PX, Ren XQ, Shi HL, Shi JS, Guo T, Wan C, Li JJ. Gastrodin regulates PI3K\/AKT-Sirt3 signaling pathway and proinflammatory mediators in activated microglia. Mol Neurobiol. 2024;61(5):2728\u201344. https:\/\/doi.org\/10.1007\/s12035-023-03743-8.","journal-title":"Mol Neurobiol"},{"key":"616_CR25","first-page":"391","volume":"22","author":"L Jun","year":"2006","unstructured":"Jun L, Zhong-Liang W, Hui-Xian W. Pharmacokinetic Study of Gastrodin in Injection. Pharm J Chin People\u2019s Lib Army. 2006;22:391\u20133.","journal-title":"Pharm J Chin People\u2019s Lib Army"},{"issue":"22","key":"616_CR26","doi-asserted-by":"publisher","first-page":"1982","DOI":"10.1016\/j.jchromb.2010.05.034","volume":"878","author":"XH Ju","year":"2010","unstructured":"Ju XH, Shi Y, Liu N, Guo DM, Cui X. Determination and pharmacokinetics of gastrodin in human plasma by HPLC coupled with photodiode array detector. J Chromatogr B. 2010;878(22):1982\u20136. https:\/\/doi.org\/10.1016\/j.jchromb.2010.05.034.","journal-title":"J Chromatogr B"},{"key":"616_CR27","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1016\/j.jpba.2014.07.004","volume":"99","author":"Y Jia","year":"2014","unstructured":"Jia Y, Li X, Xie H, Shen J, Luo J, Wang J, Wang KD, Liu Q, Kong L. Analysis and pharmacokinetics studies of gastrodin and p-hydroxybenzyl alcohol in dogs using ultra-fast liquid chromatography\u2013tandem mass spectrometry method. J Pharm Biomed Anal. 2014;99:83\u20138. https:\/\/doi.org\/10.1016\/j.jpba.2014.07.004.","journal-title":"J Pharm Biomed Anal"},{"issue":"1\u20132","key":"616_CR28","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1016\/j.ijpharm.2007.03.041","volume":"341","author":"Q Wang","year":"2007","unstructured":"Wang Q, Chen G, Zeng S. Pharmacokinetics of Gastrodin in rat plasma and CSF after in and iv. Int J Pharm. 2007;341(1\u20132):20\u20135. https:\/\/doi.org\/10.1016\/j.ijpharm.2007.03.041.","journal-title":"Int J Pharm"},{"key":"616_CR29","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1016\/j.jchromb.2012.12.011","volume":"915","author":"L Jiang","year":"2013","unstructured":"Jiang L, Dai J, Huang Z, Du Q, Lin J, Wang Y. Simultaneous determination of gastrodin and puerarin in rat plasma by HPLC and the application to their interaction on pharmacokinetics. J Chromatogr B. 2013;915:8\u201312. https:\/\/doi.org\/10.1016\/j.jchromb.2012.12.011.","journal-title":"J Chromatogr B"},{"issue":"8","key":"616_CR30","first-page":"1369","volume":"35","author":"N Liu","year":"2015","unstructured":"Liu N, Zhang ZX, Ma JG, Zhang ZJ, Tian Y. Studies on pharmacokinetics and tissue distribution of gastrodin in rats. Chin J Pharm Anal. 2015;35(8):1369\u201376.","journal-title":"Chin J Pharm Anal"},{"issue":"4","key":"616_CR31","doi-asserted-by":"publisher","first-page":"69","DOI":"10.3390\/metabo9040069","volume":"9","author":"MR Nepal","year":"2019","unstructured":"Nepal MR, Jeong KS, Kim GH, Cha DH, Kang MJ, Kim JS, Kim JH, Jeong TC. Role of intestinal microbiota in metabolism of gastrodin in vitro and in vivo. Metabolites. 2019;9(4):69. https:\/\/doi.org\/10.3390\/metabo9040069.","journal-title":"Metabolites"},{"issue":"7","key":"616_CR32","doi-asserted-by":"publisher","first-page":"e3909","DOI":"10.1002\/bmc.3909","volume":"31","author":"Z Jiang","year":"2017","unstructured":"Jiang Z, Zheng X, Gong X, Zhao C, Zhou X, Zhao Y, Yan Y. Relative tissue distribution and excretion studies of gastrodin and parishin from powder and extract of Gastrodiae Rhizoma in rat by UHPLC-ESI\u2010MS\/MS. Biomed Chromatogr. 2017;31(7):e3909. https:\/\/doi.org\/10.1002\/bmc.3909.","journal-title":"Biomed Chromatogr"},{"key":"616_CR33","doi-asserted-by":"publisher","first-page":"24","DOI":"10.3389\/fphar.2018.00024","volume":"9","author":"Y Liu","year":"2018","unstructured":"Liu Y, Gao J, Peng M, Meng H, Ma H, Cai P, Xu Y, Zhao Q, Si G. A review on central nervous system effects of gastrodin. Front Pharmacol. 2018;9:24. https:\/\/doi.org\/10.3389\/fphar.2018.00024.","journal-title":"Front Pharmacol"},{"issue":"17","key":"616_CR34","doi-asserted-by":"publisher","first-page":"9540","DOI":"10.3390\/ijms25179540","volume":"25","author":"Y Dai","year":"2024","unstructured":"Dai Y, Ban W, Yang Z. Gastrodin, a Promising Natural Small Molecule for the Treatment of Central Nervous System Disorders, and Its Recent Progress in Synthesis, Pharmacology and Pharmacokinetics. Int J Mol Sci. 2024;25(17):9540. https:\/\/doi.org\/10.3390\/ijms25179540.","journal-title":"Int J Mol Sci"},{"issue":"W1","key":"616_CR35","doi-asserted-by":"publisher","first-page":"W159","DOI":"10.1093\/nar\/gkac394","volume":"50","author":"Y Liu","year":"2022","unstructured":"Liu Y, Yang X, Gan J, Chen S, Xiao ZX, Cao Y. CB-Dock2: improved protein-ligand blind docking by integrating cavity detection, docking and homologous template fitting. Nucleic Acids Res. 2022;50(W1):W159\u201364. https:\/\/doi.org\/10.1093\/nar\/gkac394.","journal-title":"Nucleic Acids Res"},{"issue":"11","key":"616_CR36","doi-asserted-by":"publisher","first-page":"2929","DOI":"10.1038\/s41401-022-00914-6","volume":"43","author":"G Cao","year":"2022","unstructured":"Cao G, Miao H, Wang YN, Chen DQ, Wu XQ, Chen L, Guo Y, Zou L, Vaziri ND, Li P, Zhao YY. Intrarenal 1-methoxypyrene, an aryl hydrocarbon receptor agonist, mediates progressive tubulointerstitial fibrosis in mice. Acta Pharmacol Sin. 2022;43(11):2929\u201345. https:\/\/doi.org\/10.1038\/s41401-022-00914-6.","journal-title":"Acta Pharmacol Sin"},{"key":"616_CR37","doi-asserted-by":"publisher","unstructured":"Ma TT, Meng XM. TGF-\u03b2\/Smad and renal fibrosis. Renal Fibrosis: Mechanisms and Therapies. 2019:347\u2009\u2013\u200964. https:\/\/doi.org\/10.1007\/978-981-13-8871-2_16","DOI":"10.1007\/978-981-13-8871-2_16"},{"issue":"4","key":"616_CR38","doi-asserted-by":"publisher","first-page":"777","DOI":"10.1038\/s41401-023-01216-1","volume":"45","author":"M Yang","year":"2024","unstructured":"Yang M, Liu Y, Luo SL, Liu CB, Jiang N, Li CR, Zhao H, Han YC, Chen W, Li L, Sun L. DsbA-L ameliorates renal aging and renal fibrosis by maintaining mitochondrial homeostasis. Acta Pharmacol Sin. 2024;45(4):777\u201389. https:\/\/doi.org\/10.1038\/s41401-023-01216-1.","journal-title":"Acta Pharmacol Sin"},{"issue":"8","key":"616_CR39","doi-asserted-by":"publisher","first-page":"464","DOI":"10.1038\/nrm.2016.89","volume":"17","author":"JG Gall","year":"2016","unstructured":"Gall JG. DNA replication and beyond. Nat Rev Mol Cell Biol. 2016;17(8):464. https:\/\/doi.org\/10.1038\/nrm.2016.89.","journal-title":"Nat Rev Mol Cell Biol"},{"issue":"12","key":"616_CR40","doi-asserted-by":"publisher","first-page":"2811","DOI":"10.1016\/j.febslet.2006.04.033","volume":"580","author":"J Massagu\u00e9","year":"2006","unstructured":"Massagu\u00e9 J, Gomis RR. The logic of TGFbeta signaling. FEBS Lett. 2006;580(12):2811\u201320. https:\/\/doi.org\/10.1016\/j.febslet.2006.04.033.","journal-title":"FEBS Lett"},{"issue":"2","key":"616_CR41","doi-asserted-by":"publisher","first-page":"156","DOI":"10.1038\/cr.2009.5","volume":"19","author":"J Xu","year":"2009","unstructured":"Xu J, Lamouille S, Derynck R. TGF-beta-induced epithelial to mesenchymal transition. Cell Res. 2009;19(2):156\u201372. https:\/\/doi.org\/10.1038\/cr.2009.5.","journal-title":"Cell Res"},{"issue":"1","key":"616_CR42","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1038\/s41401-024-01363-z","volume":"46","author":"X Wang","year":"2025","unstructured":"Wang X, Xie X, Ni JY, Li JY, Sun XA, Xie HY, Yang NH, Guo HJ, Lu L, Ning M, Zhou L, Liu J, Xu C, Zhang W, Wen Y, Shen Q, Xu H, Lu LM. USP11 promotes renal tubular cell pyroptosis and fibrosis in UUO mice via inhibiting KLF4 ubiquitin degradation. Acta Pharmacol Sin. 2025;46(1):159\u201370. https:\/\/doi.org\/10.1038\/s41401-024-01363-z.","journal-title":"Acta Pharmacol Sin"},{"key":"616_CR43","doi-asserted-by":"publisher","first-page":"101861","DOI":"10.1016\/j.arr.2023.101861","volume":"85","author":"HJ Liu","year":"2023","unstructured":"Liu HJ, Miao H, Yang JZ, Liu F, Cao G, Zhao YY. Deciphering the role of lipoproteins and lipid metabolic alterations in ageing and ageing-associated renal fibrosis. Ageing Res Rev. 2023;85:101861. https:\/\/doi.org\/10.1016\/j.arr.2023.101861.","journal-title":"Ageing Res Rev"},{"issue":"1","key":"616_CR44","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1038\/s41401-023-01148-w","volume":"45","author":"H Miao","year":"2024","unstructured":"Miao H, Wang YN, Su W, Zou L, Zhuang SG, Yu XY, Liu F, Zhao YY. Sirtuin 6 protects against podocyte injury by blocking the renin-angiotensin system by inhibiting the Wnt1\/\u03b2-catenin pathway. Acta Pharmacol Sin. 2024;45(1):137\u201349. https:\/\/doi.org\/10.1038\/s41401-023-01148-w.","journal-title":"Acta Pharmacol Sin"},{"issue":"9","key":"616_CR45","doi-asserted-by":"publisher","first-page":"2532","DOI":"10.3390\/ijms19092532","volume":"19","author":"Y Isaka","year":"2018","unstructured":"Isaka Y. Targeting TGF-\u03b2 signaling in kidney fibrosis. Int J Mol Sci. 2018;19(9):2532. https:\/\/doi.org\/10.3390\/ijms19092532.","journal-title":"Int J Mol Sci"},{"issue":"5","key":"616_CR46","doi-asserted-by":"publisher","first-page":"4615","DOI":"10.1039\/D0FO00711K","volume":"11","author":"JQ Ma","year":"2020","unstructured":"Ma JQ, Sun YZ, Ming QL, Tian ZK, Zhang YJ, Liu CM. Effects of gastrodin against carbon tetrachloride induced kidney inflammation and fibrosis in mice associated with the AMPK\/Nrf2\/HMGB1 pathway. Food Funct. 2020;11(5):4615\u201324.","journal-title":"Food Funct"},{"key":"616_CR47","doi-asserted-by":"publisher","first-page":"108806","DOI":"10.1016\/j.intimp.2022.108806","volume":"111","author":"T Liu","year":"2022","unstructured":"Liu T, Li Y, Sun J, Tian G, Shi Z. Gitogenin suppresses lung cancer progression by inducing apoptosis and autophagy initiation through the activation of AMPK signaling. Int Immunopharmacol. 2022;111:108806. https:\/\/doi.org\/10.1016\/j.intimp.2022.108806.","journal-title":"Int Immunopharmacol"},{"issue":"4","key":"616_CR48","doi-asserted-by":"publisher","first-page":"e24","DOI":"10.1097\/IMNA-D-25-00007","volume":"12","author":"X Zhao","year":"2025","unstructured":"Zhao X, Liu Z, Wu C. Gut Microbiota and Membranous Nephropathy: Novel Molecular Mechanisms and Natural Product Therapeutic Strategies. Integr Med Nephrol Androl. 2025;12(4):e24\u201300062. https:\/\/doi.org\/10.1097\/IMNA-D-25-00007.","journal-title":"Integr Med Nephrol Androl"},{"issue":"9","key":"616_CR49","doi-asserted-by":"publisher","first-page":"2468","DOI":"10.1038\/s41401-025-01546-2","volume":"46","author":"Y Zhao","year":"2025","unstructured":"Zhao Y, Zhao QQ, Fan SJ, Xu DY, Lin LM, Luo W, Ye BZ, Zou CP, Zhu H, Zhuang ZS, Zhao YJ, Liang G. JOSD2 alleviates acute kidney injury through deubiquitinating SIRT7 and negativity regulating SIRT7-NF-\u03baB inflammatory pathway in renal tubular epithelial cells. Acta Pharmacol Sin. 2025;46(9):2468\u201381. https:\/\/doi.org\/10.1038\/s41401-025-01546-2.","journal-title":"Acta Pharmacol Sin"},{"issue":"7","key":"616_CR50","doi-asserted-by":"publisher","first-page":"379","DOI":"10.1038\/nrneph.2013.101","volume":"9","author":"RH Mak","year":"2013","unstructured":"Mak RH, Smoyer WE. Genetic screening in steroid-resistant nephrotic syndrome. Nat Rev Nephrol. 2013;9(7):379\u201381. https:\/\/doi.org\/10.1038\/nrneph.2013.101.","journal-title":"Nat Rev Nephrol"},{"key":"616_CR51","doi-asserted-by":"publisher","first-page":"111784","DOI":"10.1016\/j.cbi.2025.111784","volume":"421","author":"H Liu","year":"2025","unstructured":"Liu H, Xiang X, Shi C, Guo J, Ran T, Lin J, Dong F, Yang J, Miao H. Oxidative stress and inflammation in renal fibrosis: Novel molecular mechanisms and therapeutic targets. Chem Biol Interact. 2025;421:111784. https:\/\/doi.org\/10.1016\/j.cbi.2025.111784.","journal-title":"Chem Biol Interact"},{"issue":"12","key":"616_CR52","doi-asserted-by":"publisher","first-page":"5223","DOI":"10.7150\/ijbs.115364","volume":"21","author":"S Zhou","year":"2025","unstructured":"Zhou S, Lan Q, Xin W, Wang Y, Zhang A, Xiong J, Lv L, Li Y, Nie L, Qin S, Zhou J, Gong S, Wang S, Huang Y, Zhao J. Targeting NINJ1-Mediated Plasma Membrane Rupture in Tubular Epithelial Cell Prevents Inflammatory Response in Acute Kidney Injury. Int J Biol Sci. 2025;21(12):5223\u201339. https:\/\/doi.org\/10.7150\/ijbs.115364.","journal-title":"Int J Biol Sci"},{"issue":"8","key":"616_CR53","doi-asserted-by":"publisher","first-page":"e0136994","DOI":"10.1371\/journal.pone.0136994","volume":"10","author":"S Nakagawa","year":"2015","unstructured":"Nakagawa S, Nishihara K, Miyata H, Shinke H, Tomita E, Kajiwara M, Matsubara T, Iehara N, Igarashi Y, Yamada H, Fukatsu A, Yanagita M, Matsubara K, Masuda S. Molecular Markers of Tubulointerstitial Fibrosis and Tubular Cell Damage in Patients with Chronic Kidney Disease. PLoS ONE. 2015;10(8):e0136994. https:\/\/doi.org\/10.1371\/journal.pone.0136994.","journal-title":"PLoS ONE"},{"issue":"6","key":"616_CR54","doi-asserted-by":"publisher","first-page":"469","DOI":"10.1177\/09680519020080060301","volume":"8","author":"H Yang","year":"2002","unstructured":"Yang H, Wang H, Czura CJ, Tracey KJ. HMGB1 as a cytokine and therapeutic target. J Endotoxin Res. 2002;8(6):469\u201372. https:\/\/doi.org\/10.1177\/09680519020080060301.","journal-title":"J Endotoxin Res"},{"issue":"4","key":"616_CR55","doi-asserted-by":"publisher","first-page":"955","DOI":"10.1177\/039463201202500413","volume":"25","author":"ML Li","year":"2012","unstructured":"Li ML, Wang XF, Tan ZJ, Dong P, Gu J, Lu JH, Wu XS, Zhang L, Ding QC, Wu WG, Rao LH, Mu JS, Yang JH, Weng H, Ding Q, Zhang WJ, Chen L, Liu YB. Ethyl pyruvate administration suppresses growth and invasion of gallbladder cancer cells via downregulation of HMGB1-RAGE axis. Int J Immunopathol Pharmacol. 2012;25(4):955\u201365. https:\/\/doi.org\/10.1177\/039463201202500413.","journal-title":"Int J Immunopathol Pharmacol"},{"issue":"6","key":"616_CR56","doi-asserted-by":"publisher","first-page":"325","DOI":"10.1038\/nrneph.2016.48","volume":"12","author":"XM Meng","year":"2016","unstructured":"Meng XM, Nikolic-Paterson DJ, Lan HY. TGF-\u03b2: the master regulator of fibrosis. Nat Rev Nephrol. 2016;12(6):325\u201338. https:\/\/doi.org\/10.1038\/nrneph.2016.48.","journal-title":"Nat Rev Nephrol"},{"issue":"2","key":"616_CR57","doi-asserted-by":"publisher","first-page":"249","DOI":"10.1093\/toxres\/tfab003","volume":"10","author":"ZK Tian","year":"2021","unstructured":"Tian ZK, Zhang YJ, Feng ZJ, Jiang H, Cheng C, Sun JM, Liu CM. Nephroprotective effect of gastrodin against lead-induced oxidative stress and inflammation in mice by the GSH, Trx, Nrf2 antioxidant system, and the HMGB1 pathway. Toxicol Res (Camb). 2021;10(2):249\u201363. https:\/\/doi.org\/10.1093\/toxres\/tfab003.","journal-title":"Toxicol Res (Camb)"},{"issue":"1","key":"616_CR58","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1186\/s11658-023-00462-9","volume":"28","author":"Y Chen","year":"2023","unstructured":"Chen Y, Ye X, Escames G, Lei W, Zhang X, Li M, Jing T, Yao Y, Qiu Z, Wang Z, Acu\u00f1a-Castroviejo D. The NLRP3 inflammasome: contributions to inflammation-related diseases. Cell Mol Biol Lett. 2023;28(1):51. https:\/\/doi.org\/10.1186\/s11658-023-00462-9.","journal-title":"Cell Mol Biol Lett"},{"issue":"1","key":"616_CR59","doi-asserted-by":"publisher","first-page":"480","DOI":"10.1007\/s00018-024-05532-5","volume":"81","author":"XJ Li","year":"2024","unstructured":"Li XJ, Shan QY, Wu X, Miao H, Zhao YY. Gut microbiota regulates oxidative stress and inflammation: a double-edged sword in renal fibrosis. Cell Mol Life Sci. 2024;81(1):480. https:\/\/doi.org\/10.1007\/s00018-024-05532-5.","journal-title":"Cell Mol Life Sci"},{"key":"616_CR60","doi-asserted-by":"publisher","unstructured":"Collins AJ, Foley RN, Gilbertson DT, Chen SC. Kidney Int Suppl. 2015;5(1):2\u20137. https:\/\/doi.org\/10.1038\/kisup.2015.2. United States Renal Data System public health surveillance of chronic kidney disease and end-stage renal disease.","DOI":"10.1038\/kisup.2015.2"},{"issue":"4","key":"616_CR61","doi-asserted-by":"publisher","first-page":"194967","DOI":"10.1016\/j.bbagrm.2023.194967","volume":"1866","author":"Y Sun","year":"2023","unstructured":"Sun Y, Jin D, Zhang Z, Ji H, An X, Zhang Y, Yang C, Sun W, Zhang Y, Duan Y, Kang X. N6-methyladenosine (m6A) methylation in kidney diseases: mechanisms and therapeutic potential. Biochim Biophys Acta Gene Regul Mech. 2023;1866(4):194967. https:\/\/doi.org\/10.1016\/j.bbagrm.2023.194967.","journal-title":"Biochim Biophys Acta Gene Regul Mech"},{"issue":"6","key":"616_CR62","doi-asserted-by":"publisher","first-page":"630","DOI":"10.1159\/00052053","volume":"106","author":"Y Zheng","year":"2022","unstructured":"Zheng Y, Zhang N, Bai F. Gastrodin Pretreatment Alleviates Renal Ischemia-Reperfusion Injury. Urol Int. 2022;106(6):630\u20137. https:\/\/doi.org\/10.1159\/00052053.","journal-title":"Urol Int"},{"key":"616_CR63","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1016\/j.freeradbiomed.2023.07.014","volume":"207","author":"YN Wang","year":"2023","unstructured":"Wang YN, Miao H, Yu XY, Guo Y, Su W, Liu F, Cao G, Zhao YY. Oxidative stress and inflammation are mediated via aryl hydrocarbon receptor signalling in idiopathic membranous nephropathy. Free Radic Biol Med. 2023;207:89\u2013106. https:\/\/doi.org\/10.1016\/j.freeradbiomed.2023.07.014.","journal-title":"Free Radic Biol Med"},{"issue":"6","key":"616_CR64","doi-asserted-by":"publisher","first-page":"2008","DOI":"10.7150\/ijbs.93598","volume":"20","author":"J Lu","year":"2024","unstructured":"Lu J, Sun W, Liu B, Zhang J, Wang R, Goltzman D, Miao D. Chk2 Modulates Bmi1-Deficiency-Induced Renal Aging and Fibrosis via Oxidative Stress, DNA Damage, and p53\/TGF\u03b21-Induced Epithelial-Mesenchymal Transition. Int J Biol Sci. 2024;20(6):2008\u201326. https:\/\/doi.org\/10.7150\/ijbs.93598.","journal-title":"Int J Biol Sci"},{"key":"616_CR65","doi-asserted-by":"publisher","first-page":"166","DOI":"10.3389\/fendo.2014.00166","volume":"5","author":"R Yacoub","year":"2014","unstructured":"Yacoub R, Lee K, He JC. The role of SIRT1 in diabetic kidney disease. Front Endocrinol. 2014;5:166. https:\/\/doi.org\/10.3389\/fendo.2014.00166.","journal-title":"Front Endocrinol"},{"key":"616_CR66","doi-asserted-by":"publisher","first-page":"801303","DOI":"10.3389\/fendo.2022.801303","volume":"13","author":"W Qi","year":"2022","unstructured":"Qi W, Hu C, Zhao D, Li X. SIRT1\u2013SIRT7 in diabetic kidney disease: Biological functions and molecular mechanisms. Front Endocrinol (Lausanne). 2022;13:801303. https:\/\/doi.org\/10.3389\/fendo.2022.801303.","journal-title":"Front Endocrinol (Lausanne)"},{"issue":"4","key":"616_CR67","doi-asserted-by":"publisher","first-page":"258","DOI":"10.1159\/000440967","volume":"1","author":"Y Guan","year":"2016","unstructured":"Guan Y, Hao CM. SIRT1 and Kidney Function. Kidney Dis (Basel). 2016;1(4):258\u201365. https:\/\/doi.org\/10.1159\/000440967.","journal-title":"Kidney Dis (Basel)"},{"issue":"Pt 3","key":"616_CR68","doi-asserted-by":"publisher","first-page":"117282","DOI":"10.1016\/j.jep.2023.117282","volume":"319","author":"CW Qiu","year":"2024","unstructured":"Qiu CW, Chen B, Zhu HF, Liang YL, Mao LS. Gastrodin alleviates cisplatin nephrotoxicity by inhibiting ferroptosis via the SIRT1\/FOXO3A\/GPX4 signaling pathway. J Ethnopharmacol. 2024;319(Pt 3):117282. https:\/\/doi.org\/10.1016\/j.jep.2023.117282.","journal-title":"J Ethnopharmacol"},{"key":"616_CR69","doi-asserted-by":"publisher","first-page":"401","DOI":"10.1146\/annurev-pharmtox-011112-140320","volume":"53","author":"Q Ma","year":"2013","unstructured":"Ma Q. Role of nrf2 in oxidative stress and toxicity. Annu Rev Pharmacol Toxicol. 2013;53:401\u201326. https:\/\/doi.org\/10.1146\/annurev-pharmtox-011112-140320.","journal-title":"Annu Rev Pharmacol Toxicol"},{"issue":"17","key":"616_CR70","doi-asserted-by":"publisher","first-page":"1727","DOI":"10.1089\/ars.2017.7342","volume":"29","author":"C Tonelli","year":"2018","unstructured":"Tonelli C, Chio IIC, Tuveson DA. Transcriptional Regulation by Nrf2. Antioxid Redox Signal. 2018;29(17):1727\u201345. https:\/\/doi.org\/10.1089\/ars.2017.7342.","journal-title":"Antioxid Redox Signal"},{"key":"616_CR71","doi-asserted-by":"publisher","first-page":"1700004","DOI":"10.3892\/etm.2022.11712","volume":"16","author":"Y Luo","year":"2025","unstructured":"Luo Y, Long M, Wu X, Zeng L. Targeting ferroptosis: novel therapeutic approaches and intervention strategies for kidney diseases. Front Immunol. 2025;16:1700004. https:\/\/doi.org\/10.3892\/etm.2022.11712.","journal-title":"Front Immunol"},{"issue":"2","key":"616_CR72","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1038\/s41419-020-2298-2","volume":"11","author":"J Li","year":"2020","unstructured":"Li J, Cao F, Yin HL, Huang ZJ, Lin ZT, Mao N, Sun B, Wang G. Ferroptosis: past, present and future. Cell Death Dis. 2020;11(2):88. https:\/\/doi.org\/10.1038\/s41419-020-2298-2.","journal-title":"Cell Death Dis"},{"issue":"6","key":"616_CR73","doi-asserted-by":"publisher","first-page":"1327","DOI":"10.1007\/s10735-024-10273-7","volume":"55","author":"S Zhao","year":"2024","unstructured":"Zhao S, Pan Q, Lin X, Li X, Qu L. Gastrodin ameliorates diabetic nephropathy by activating the AMPK\/Nrf2 pathway. J Mol Histol. 2024;55(6):1327\u201339. https:\/\/doi.org\/10.1007\/s10735-024-10273-7.","journal-title":"J Mol Histol"}],"container-title":["DARU Journal of Pharmaceutical Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40199-026-00616-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s40199-026-00616-y","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40199-026-00616-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,6]],"date-time":"2026-06-06T18:36:34Z","timestamp":1780770994000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s40199-026-00616-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6,6]]},"references-count":73,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["616"],"URL":"https:\/\/doi.org\/10.1007\/s40199-026-00616-y","relation":{},"ISSN":["2008-2231"],"issn-type":[{"value":"2008-2231","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,6,6]]},"assertion":[{"value":"7 January 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 May 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 June 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This article does not contain any studies with human participants or animals performed by any of the authors.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed consent"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"All the authors declare that they have no conflict of interest.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}],"article-number":"32"}}